M&T Bank Corp decreased its position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 3.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,154 shares of the company’s stock after selling 1,076 shares during the quarter. M&T Bank Corp’s holdings in Avantor were worth $659,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Cibc World Market Inc. lifted its position in Avantor by 1.3% during the first quarter. Cibc World Market Inc. now owns 36,082 shares of the company’s stock worth $1,220,000 after purchasing an additional 480 shares during the period. Amalgamated Bank lifted its position in Avantor by 0.8% during the fourth quarter. Amalgamated Bank now owns 67,848 shares of the company’s stock worth $1,431,000 after purchasing an additional 521 shares during the period. Gulf International Bank UK Ltd lifted its holdings in shares of Avantor by 0.5% in the fourth quarter. Gulf International Bank UK Ltd now owns 121,185 shares of the company’s stock worth $2,555,000 after acquiring an additional 650 shares during the last quarter. Yousif Capital Management LLC lifted its holdings in shares of Avantor by 7.9% in the first quarter. Yousif Capital Management LLC now owns 8,870 shares of the company’s stock worth $300,000 after acquiring an additional 650 shares during the last quarter. Finally, First Hawaiian Bank lifted its holdings in shares of Avantor by 5.0% in the first quarter. First Hawaiian Bank now owns 17,329 shares of the company’s stock worth $366,000 after acquiring an additional 830 shares during the last quarter. Institutional investors own 89.04% of the company’s stock.
Avantor Stock Performance
NYSE AVTR opened at $21.70 on Friday. The company has a fifty day simple moving average of $21.17 and a 200 day simple moving average of $21.14. Avantor, Inc. has a 12-month low of $17.91 and a 12-month high of $26.26. The company has a current ratio of 1.61, a quick ratio of 1.04 and a debt-to-equity ratio of 1.11. The company has a market cap of $14.67 billion, a P/E ratio of 34.44, a PEG ratio of 1.25 and a beta of 1.31.
Insider Activity at Avantor
In other Avantor news, EVP Frederic Vanderhaegen sold 25,000 shares of the firm’s stock in a transaction on Friday, August 25th. The stock was sold at an average price of $21.47, for a total transaction of $536,750.00. Following the transaction, the executive vice president now directly owns 160,735 shares in the company, valued at approximately $3,450,980.45. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of research firms have recently commented on AVTR. Barclays increased their target price on shares of Avantor from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, July 31st. Royal Bank of Canada raised their price objective on shares of Avantor from $27.00 to $28.00 and gave the company an “outperform” rating in a report on Monday, July 31st. Bank of America dropped their price objective on shares of Avantor from $27.00 to $24.00 and set a “buy” rating for the company in a report on Sunday, July 30th. William Blair downgraded shares of Avantor from an “outperform” rating to a “market perform” rating in a research report on Monday, July 31st. Finally, Morgan Stanley decreased their target price on shares of Avantor from $26.00 to $24.00 and set an “overweight” rating for the company in a research report on Monday, July 31st. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.12.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
- Five stocks we like better than Avantor
- What is Insider Trading? What You Can Learn from Insider Trading
- MarketBeat Week in Review – 8/28 – 9/1
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- Why is the Ex-Dividend Date Significant to Investors?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.